Cirrhosis: Nursing process (ADPIE)

2,566views

Cirrhosis: Nursing process (ADPIE)

Synthesis Of Nursing Practice

Synthesis Of Nursing Practice

Left-sided heart failure: Nursing process (ADPIE)
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Normal heart sounds
Abnormal heart sounds
Anatomy of the heart
Congenital heart defects: Clinical
Cardiac conduction system
Post-COVID syndrome: Heart, lungs and clotting
Heart blocks: Pathology review
Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Antihyperlipidemics - Statins: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Applying sterile gloves
Cardioversion
Maintaining an airway
Removing an intravenous line
Venipuncture for blood sampling
Clinical Skills: Abdominal Assessment
Clinical skills: Medication administration - Giving transcutaneous medication
Clinical skills: Patient controlled analgesia
COVID-19: Nursing

Notes

CIRRHOSIS

KEY POINTS
NOTES
PATIENT REPORT
  • 55-year-old woman
  • History cirrhosis and hepatitis C
  • Increased abdominal distension, loss of appetite, and fatigue 

PATHOPHYSIOLOGY
  • Cirrhosis
    • Liver develops irreversible scarring from chronic inflammation
    • Liver replaces injured tissue with regenerative nodules
    • Nodules surrounded by collagen-rich scar tissue
    • Inflammation causes bands of scar tissue between nodules
    • Scar tissues compresses blood supply to liver
    • Increased venous pressure and portal hypertension
    • Peripheral edema and ascites occur
    • Impaired ability to produce albumin
  • Risk factors
    • Modifiable
      • Alcohol use
    • Non-modifiable
      • Viral hepatitis
      • Autoimmune hepatitis
      • Other autoimmune disorders
      • Non-alcoholic fatty liver disease
      • Genetic disorders

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • Laboratory tests
    • Ultrasound
    • CT
    • MRI
    • Liver biopsy
  • Treatment
    • Address underlying cause
    • Lifestyle modifications

ASSESSMENT
  • Increased bloating
  • No energy
  • Needs frequent rest periods
  • 5'5''
  • 157 lbs (71.2 kg)
  • Temperature: 98.4 F (36.9 C)
  • Heart rate: 92
  • Respiratory rate: 24
  • Clear lungs
  • Blood pressure: 110/58 mmHg
  • Oxygen saturation: 96% room air
  • Jaundice
  • Abdominal girth: 45 inches (114 cm)
  • Distended veins on abdomen
  • 2+ pitting edema
  • Poor appetitie
  • Red blood cells: 2.7 million/mm(2.7 x 1012/L)
  • Platelets: 86,000/mm(86 x 109/L)
  • Hemoglobin: 9.9 g/dL (6.14 mmol/L)
  • Total bilirubin: 2.0 mg/dL (34.2 μmol/L)
  • Albumin: 3.2 g/dL (32 g/L)
  • Liver enzymes: elevated

NURSING DIAGNOSES
  • Fluid volume excess related to third spacing
  • Imbalanced nutrition related to decreased appetite
  • Fatigue related to anemia
  • Risk for bleeding related to thrombocytopenia
  • Knowledge deficit related to cirrhosis management

PLANNING
  • Decrease ascites and peripheral edema
  • Improve appetite
  • More healthy foods
  • Free from bleeding
  • Hemoglobin normalize
  • Less fatigue
  • Verbalize understanding of plan

IMPLEMENTATION
  • Administer medications as prescribed
  • Explain dietary changes
  • Teach about bleeding precautions
  • Instruct on when to seek emergency care

EVALUATION
  • 5'5''
  • 150 lbs (68 kg)
  • Temperature: 98.0 F (36.7 C)
  • Heart rate: 90
  • Respiratory rate: 18
  • Clear lungs
  • Blood pressure: 128/72 mmHg
  • Oxygen saturation: 96% room air
  • Jaundiced
  • No new bruising
  • No bleeding
  • Abdominal girth: 41 inches (104 cm)
  • Periumbilical veins less visible
  • 1+ edema
  • Improved appetite
  • Red blood cells: 3.3 million/mm(3.3 x1012/L)
  • Platelets: 102,000/mm(102 x 109/L)
  • Hemoglobin: 10.7 g/dL (6.64 mmol/L)
  • Total bilirubin: 1.9 mg/dL (32.5 μmol/L)
  • Albumin: 3.3 g/dL (33 g/L)
  • Not resting as often

Transcript

Watch video only

Rita Davis is a 55-year-old African American woman with a history of cirrhosis from chronic hepatitis C infection.

Today, Rita is visiting the clinic for concerns about increased abdominal distention, loss of appetite, and fatigue.

Cirrhosis is a condition in which the liver, a large organ in the right upper quadrant of the abdomen, becomes irreversibly scarred from chronic inflammation.

Because the liver has many functions related to digestion, metabolism, detoxification, and production of important molecules the body needs, damage to the liver can have widespread impact on a person’s health.

Let’s look at some of the contributing factors for chronic liver inflammation.

One of the most common modifiable risk factors is long-term alcohol use.

On the other hand, non-modifiable risk factors for cirrhosis include viral hepatitis, autoimmune hepatitis, and other autoimmune disorders, including primary biliary cholangitis and primary sclerosing cholangitis, which can cause liver injury through progressive scarring of the bile ducts.

Liver injury can also occur from non-alcoholic fatty liver disease, in which fat cells build up in the liver.

Genetic disorders like hemochromatosis and Wilson’s disease can cause inflammation from accumulating elements like iron or copper in the liver, whereas alpha-1 antitrypsin deficiency creates malformed proteins that become stuck in the liver.

The liver is highly regenerative, meaning that after injury it replaces injured tissue with regenerative nodules.

These nodules are colonies of liver cells, or hepatocytes, surrounded by collagen-rich scar tissue.

This causes the smooth liver tissue to become bumpy and stiff.

Over time, inflammation causes bands of scar tissue to form between nodules.

As the scar tissue grows, it compresses the network of blood supply in the liver.

This leads to increased venous pressure and portal hypertension, which occurs as blood backs up into the portal vein.

Now, higher portal vein pressure means that fluid in blood vessels is more likely to get pushed into tissues, leading to peripheral edema, as well as into large open spaces, like the peritoneal cavity, which is known as ascites.

To make matters worse, damage to the liver impairs its ability to make albumin, which is a protein in blood that helps keep fluid within the blood vessels.

Hypoalbuminemia, or low albumin in the blood, contributes to ascites as well as peripheral edema.

Ascites typically presents as a distended abdomen, which can be detected by the presence of a fluid wave that means there is free fluid in the abdomen; as well as shifting dullness, which presents as a change during percussion from tympany, where fluid is, to dullness when the fluid moves as the client’s position is changed.

Unfortunately, ascites fluid can become infected without an obvious cause, called spontaneous bacterial peritonitis.

Signs of this complication include fever, abdominal pain and tenderness, nausea, vomiting, and altered mental status.

The increased venous pressure within the gastrointestinal tract ultimately leads to dilation of the gastrointestinal veins, which become fragile, and are called varicose veins, or varices.

The veins can often be seen as radiating out from the umbilicus, a condition called caput medusae.

On the other hand, varices in the esophagus or stomach are the most prone to rupture and bleeding, which can be a life-threatening complication.

Signs of variceal bleeding include hematemesis, melena, hypotension, and tachycardia.

As pressure in the portal system builds, the spleen can become distended, causing splenomegaly.

The enlarged spleen traps red blood cells, leading to anemia, and white blood cells, causing leukopenia and increasing the risk of infection.

Also platelets become trapped within the spleen, causing thrombocytopenia, resulting in easy bruising or bleeding.

Bleeding and bruising are also a result of the liver not being able to synthesize clotting factors, like prothrombin.

When the blood takes longer to clot, PTT, PT, and INR levels may be increased.

Over time, the declining liver function means that toxins and waste products don’t get metabolized.

Elevated levels of bilirubin circulating in the body causes jaundice and pruritus.

Ammonia and other toxins can build up in the brain leading to hepatic encephalopathy.

This neurological complication of liver disease causes a flapping tremor, called asterixis, as well as changes in mental status or behavior, and can ultimately lead to coma.

Impaired liver function means that hormones like estrogen don’t get metabolized, so their levels increase, leading to the development palmar erythema.

In males, testicular atrophy, gynecomastia, and loss of sex drive can be present.

On the other hand, premenopausal females may experience an absence of menstruation, while older females may experience vaginal bleeding.

Finally, impaired metabolism by the liver of vitamin D can cause loss of bone density and osteoporosis.

Diagnosing cirrhosis involves analyzing blood work, which most commonly shows increasing serum levels of ALT, AST, ALP, or GGT, as these liver enzymes leak into the bloodstream from damaged liver cells.

Liver nodules associated with hepatic injury may be seen on ultrasound, CT scan, or MRI.

Magnetic resonance elastography uses an MRI along with low-frequency vibrations to assess for stiffening of the liver.

Finally, a liver biopsy can be done to confirm the stage or exact cause of cirrhosis.

Treatment of cirrhosis involves preventing further liver damage by addressing the underlying cause.

Lifestyle changes include avoiding alcohol and hepatotoxic medications, such as acetaminophen, as well as eating a healthy low-sodium diet, and preventing infections with good hand hygiene and avoiding people who are sick.

Antihypertensives like beta-blockers are used to reduce portal hypertension.